3 DRUGMAKERS SEEK EU OK FOR HIV DRUG

Drug makers Bristol-Myers Squibb Co., Gilead Sciences Inc., and Merck & Co. said Monday that they filed a marketing application with European regulators to get the once-a-day single tablet HIV drug Atripla approved. Yahoo Finance (http://biz.yahoo.com/ap/061009/bristol_myers_atripla.html?.v=1)